Bleichroeder Acquisition Corp (NASDAQ:BACQ) shares are trending higher Thursday following commentary from Citron Research highlighting the SPAC's risk-reward profile.
Merlin, a leading developer of assured, autonomous flight technology for defense customers, today announced the signing of a Cooperative Research and Development Agreement (CRADA) with the United States Air Force (USAF) to advance autonomous capabilities that will improve mission resilience and adaptability in contested and degraded environments. The work will combine operational insight from the USAF with Merlin’s expertise in autonomy architecture, human-machine teaming, and advanced mission software, leveraging the company’s position as the leading defense prime contractor for AI in aviation and its recently announced path to go public through a business combination with Inflection Point Acquisition Corp. IV (Nasdaq: BACQ) to accelerate autonomy on military platforms. The result of this work will be design enhancements that improve mission assurance, reduce operator workload, and create greater survivability across diverse operational scenarios.
Merlin, a leading developer of assured, autonomous flight technology for defense customers, and Bleichroeder Acquisition Corp. I (BAC), a SPAC led and backed by the management team of Inflection Point Asset Management (Inflection Point), which will be renamed Inflection Point Acquisition Corp IV (Nasdaq: BACQ), announced today that they have entered into a definitive business combination agreement (BCA). The proposed transaction is expected to close in early 2026, subject to customary closing conditions, including regulatory and shareholder approval. As the leading defense prime contractor for AI in aviation, the deal values Merlin at $800 million pre-money, and has over $125 million in committed PIPE capital, $78 million of which has been funded at the BCA signing to further accelerate growth.
